The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Whole-genome sequencing reveals important role for TBK1 and OPTN mutations in frontotemporal lobar degeneration without motor neuron disease
Open accessAbstract
Frontotemporal lobar degeneration with TAR DNA-binding protein 43 inclusions (FTLD-TDP) is the most common pathology associated with frontotemporal dementia (FTD). Repeat expansions in chromosome 9 open reading frame 72 (C9ORF72) and mutations in progranulin (GRN) are the major known genetic causes of FTLD-TDP; however, the genetic etiology in the majority of FTLD-TDP remains unexplained. In this study, we performed whole-genome sequencing in 104 pathologically confirmed FTLD-TDP patients from the Mayo Clinic brain bank negative for C9ORF72 and GRN mutations and report on the contribution of rare single nucleotide and copy number variants in 21 known neurodegenerative disease genes. Interestingly, we identified 5 patients (4.8 %) with variants in optineurin (OPTN) and TANK-binding kinase 1 (TBK1) that are predicted to be highly pathogenic, including two double mutants. Case A was a compound heterozygote for mutations in OPTN, carrying the p.Q235* nonsense and p.A481V missense mutation in trans, while case B carried a deletion of OPTN exons 13-15 (p.Gly538Glufs*27) and a loss-of-function mutation (p.Arg117*) in TBK1. Cases C-E carried heterozygous missense mutations in TBK1, including the p.Glu696Lys mutation which was previously reported in two amyotrophic lateral sclerosis (ALS) patients and is located in the OPTN binding domain. Quantitative mRNA expression and protein analysis in cerebellar tissue showed a striking reduction of OPTN and/or TBK1 expression in 4 out of 5 patients supporting pathogenicity in these specific patients and suggesting a loss-of-function disease mechanism. Importantly, neuropathologic examination showed FTLD-TDP type A in the absence of motor neuron disease in 3 pathogenic mutation carriers. In conclusion, we highlight TBK1 as an important cause of pure FTLD-TDP, identify the first OPTN mutations in FTLD-TDP, and suggest a potential oligogenic basis for at least a subset of FTLD-TDP patients. Our data further add to the growing body of evidence linking ALS and FTD and suggest a key role for the OPTN/TBK1 pathway in these diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Supporting the link between ALS and FTD, TBK1 mutations have also been identified in FTD patients, and in fact occur more frequently in patients with combined ALS-FTD than in those with ALS alone [207–209].”
From Autophagy and ALS: mechanistic insights and therapeutic implications (2022) · cites this paper as [209]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
NIH Image to ImageJ: 25 years of image analysis
Schneider, C. A., Rasband, W. S., & Eliceiri, K. W. (2012) · Nature Methods · doi:10.1038/nmeth.2089 · Cited by 64,638
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
Li, Y., Jiang, Q. L., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,351
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis
Neumann, M., Sampathu, D. M., Kwong, L. K., Truax, A. C., Micsenyi, M. C., Chou, T. T., Bruce, J., Schuck, T., Grossman, M., Clark, C. M., et al. (2006) · Science · doi:10.1126/science.1134108 · Cited by 6,576
DeJesus-Hernandez, M., Mackenzie, I. R., Boeve, B. F., Boxer, A. L., Baker, M., Rutherford, N. J., Nicholson, A. M., Finch, N. A., Flynn, H., Adamson, J., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.011 · Cited by 4,936 · cited 13×
“The most striking evidence, however, came from the identification of repeat expansions in C9ORF72 as a common cause of FTD, ALS and mixed FTD-ALS patients, which firmly established a genetic link between these disorders [14, 45].”
BackgroundInfluentialSelf-citationA Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD
Renton, A. E., Majounie, E., Waite, A., Simón-Sánchez, J., Rollinson, S., Gibbs, J. R., Schymick, J. C., Laaksovirta, H., van Swieten, J. C., Myllykangas, L., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.010 · Cited by 4,409
Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., et al. (1998) · Nature · doi:10.1038/31508 · Cited by 3,498
Self-citationArai, T., Hasegawa, M., Akiyama, H., Ikeda, K., Nonaka, T., Mori, H., Mann, D., Tsuchiya, K., Yoshida, M., Hashizume, Y., et al. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.10.093 · Cited by 2,732
Mutations in FUS, an RNA Processing Protein, Cause Familial Amyotrophic Lateral Sclerosis Type 6
Vance, C. A., Rogelj, B., Hortobágyi, T., Vos, K. J. D., Nishimura, A. L., Sreedharan, J., Hu, X., Smith, B. N., Ruddy, D., Wright, P. D., et al. (2009) · Science · doi:10.1126/science.1165942 · Cited by 2,625
Mutations in the FUS/TLS Gene on Chromosome 16 Cause Familial Amyotrophic Lateral Sclerosis
Kwiatkowski, T. J., Bosco, D. A., LeClerc, A. L., Tamrazian, E., Vanderburg, C. R., Russ, C., Davis, A., Gilchrist, J. M., Kasarskis, E. J., Munsat, T. L., et al. (2009) · Science · doi:10.1126/science.1166066 · Cited by 2,624
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 312
Mutational analysis of TBK1 in Taiwanese patients with amyotrophic lateral sclerosis
Tsai, P., Liu, Y., Lin, K., Liu, Y., Liao, Y., Hsiao, C.-T., Soong, B., Yip, P., & Lee, Y. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.12.022 · Cited by 54
Pfeffer, G., Lee, G., Pontifex, C. S., Fanganiello, R. D., Peck, A., Weihl, C. C., & Kimonis, V. E. (2022) · Genes · doi:10.3390/genes13060963 · Cited by 49
The role of de novo mutations in adult-onset neurodegenerative disorders
Nicolas, G., & Veltman, J. A. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1939-3 · Cited by 53
Self-citationTBK1 is associated with ALS and ALS-FTD in Sardinian patients
Borghero, G., Pugliatti, M., Marrosu, F., Marrosu, M. G., Murru, M. R., Floris, G., Cannas, A., Occhineri, P., Cau, T. B., Loi, D., et al. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.03.028 · Cited by 54
Martínez-Noël, G., Luck, K., Kühnle, S., Desbuleux, A., Szajner, P., Galligan, J. T., Rodriguez, D., Zheng, L., Boyland, K. A., Leclere, F., et al. (2018) · Journal of Molecular Biology · doi:10.1016/j.jmb.2018.01.021 · Cited by 53
Genetic epidemiology of motor neuron disease-associated variants in the Scottish population
Black, H. A., Leighton, D., Cleary, E. M., Rose, E., Stephenson, L. J., Colville, S., Ross, D. B., Warner, J. P., Porteous, M. E., Gorrie, G., et al. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.12.013 · Cited by 50
Pozzi, L., Valenza, F., Mosca, L., Mas, A. D., Domi, T., Romano, A., Tarlarini, C., Falzone, Y., Tremolizzo, L., Sorarú, G., et al. (2017) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2017-316174 · Cited by 50
Duan, W., Guo, M., Yi, L., Zhang, J., Bi, Y., Liu, Y., Li, Y., Li, Z., Ma, Y., Zhang, G., et al. (2019) · Aging · doi:10.18632/aging.101936 · Cited by 51
The role of CHMP2BIntron5 in autophagy and frontotemporal dementia
Krasniak, C. S., & Ahmad, S. T. (2016) · Brain Research · doi:10.1016/j.brainres.2016.02.051 · Cited by 48
Genetic architecture of common non-Alzheimer’s disease dementias
Guerreiro, R. J., Gibbons, E., Tábuas‐Pereira, M., Kun‐Rodrigues, C., Cordeiro, G., & Brás, J. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104946 · Cited by 48
Koriath, C., Bocchetta, M., Brotherhood, E., Woollacott, I., Norsworthy, P. J., Simón‐Sánchez, J., Blauwendraat, C., Dick, K. M., Gordón, E., Harding, S. R., et al. (2016) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2016.10.003 · Cited by 47
Neuroinflammation in Amyotrophic Lateral Sclerosis: Role of Redox (dys)Regulation
D’Ambrosi, N., Cozzolino, M., & Carrı̀, M. T. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7271 · Cited by 44
Neuroimaging in genetic frontotemporal dementia and amyotrophic lateral sclerosis
Häkkinen, S., Chu, S. A., & Lee, S. E. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105063 · Cited by 42
OPTN 691_692insAG is a founder mutation causing recessive ALS and increased risk in heterozygotes
Goldstein, O., Nayshool, O., Nefussy, B., Traynor, B. J., Renton, A. E., Gana‐Weisz, M., Drory, V. E., & Orr‐Urtreger, A. (2016) · Neurology · doi:10.1212/wnl.0000000000002334 · Cited by 45
RNA Binding Proteins and the Pathogenesis of Frontotemporal Lobar Degeneration
Hofmann, J. W., Seeley, W. W., & Huang, E. J. (2018) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-012418-012955 · Cited by 50
Clayton, E. L., Milioto, C., Muralidharan, B., Norona, F. E., Edgar, J. R., Soriano, A., Jafar‐Nejad, P., Rigo, F., Collinge, J., & Isaacs, A. M. (2018) · Brain · doi:10.1093/brain/awy284 · Cited by 45
The Genetics of C9orf72 ExpansionsPreprint
Gijselinck, I., Cruts, M., & Broeckhoven, C. V. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026757 · Cited by 43
A critical role of Hrd1 in the regulation of optineurin degradation and aggresome formation
Mao, J., Qin, X., Liu, C., Ying, Z., Wang, H., & Wang, G. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx096 · Cited by 41
Modelling amyotrophic lateral sclerosis in rodents
Todd, T. W., & Petrucelli, L. (2022) · Nature reviews. Neuroscience · doi:10.1038/s41583-022-00564-x · Cited by 44
Konopka, A., & Atkin, J. D. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103137 · Cited by 41
Quan, M., Song, X., Liu, H.-J., Deng, X.-H., Hou, H.-Q., Li-ping, C., Ma, T., Han, X., He, X.-X., Jia, Z., et al. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1438-z · Cited by 42
Amyotrophic lateral sclerosis: recent genetic highlights
White, M. A., & Sreedharan, J. (2016) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000367 · Cited by 40
Geier, E. G., Bourdenx, M., Storm, N. J., Cochran, J. N., Sirkis, D. W., Hwang, J.-H., Bonham, L. W., Ramos, E. M., Diaz, A., Van Berlo, V., et al. (2019) · Acta Neuropathologica · doi:10.1007/s00401-018-1925-9 · Cited by 39
Cui, R., Tuo, M., Li, P., & Zhou, C. (2018) · Neurological Sciences · doi:10.1007/s10072-018-3246-0 · Cited by 38
Emerging genetic complexity and rare genetic variants in neurodegenerative brain diseases
Perrone, F., Cacace, R., van der Zee, J., & Broeckhoven, C. V. (2021) · Genome Medicine · doi:10.1186/s13073-021-00878-y · Cited by 38
Giannoccaro, M. P., Bartoletti‐Stella, A., Piras, S., Pession, A., Massis, P. D., Oppi, F., Maserati, M. S., Pasini, E., Baiardi, S., Avoni, P., et al. (2017) · Journal of Neurology · doi:10.1007/s00415-017-8540-x · Cited by 37
Clinicopathologic characterization and abnormal autophagy of CSF1R-related leukoencephalopathy
Tian, W., Zhan, F., Liu, Q. F., Luan, X., Zhang, C., Shang, L., Zhang, B., Pan, S., Miao, F., Hu, J., et al. (2019) · Translational Neurodegeneration · doi:10.1186/s40035-019-0171-y · Cited by 36
Genetic inactivation of RIP1 kinase does not ameliorate disease in a mouse model of ALS
Domínguez, S. L., Varfolomeev, E. E., Brendza, R. P., Stark, K., Tea, J. S., Imperio, J., Ngu, H., Earr, T., Foreman, O., Webster, J. D., et al. (2020) · Cell Death and Differentiation · doi:10.1038/s41418-020-00625-7 · Cited by 35
Cochran, J. N., McKinley, E., Cochran, J. N., Amaral, M. D., Moyers, B. A., Lasseigne, B. N., Gray, D. E., Lawlor, J. M. J., Prokop, J. W., Geier, E. G., et al. (2019) · Molecular Case Studies · doi:10.1101/mcs.a003491 · Cited by 37
Underlying genetic variation in familial frontotemporal dementia: sequencing of 198 patients
Mol, M. O., van Rooij, J., Wong, T. H., Melhem, S., Verkerk, A. J. M. H., Kievit, A. J. A., van Minkelen, R., Rademakers, R., Pottier, C. P., Kaat, L. D., et al. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.07.014 · Cited by 40
Self-citationJagaraj, C. J., Parakh, S., & Atkin, J. D. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.581950 · Cited by 38
Lattante, S., Doronzio, P. N., Marangi, G., Conte, A., Bisogni, G., Bernardo, D., Russo, T., Lamberti, D., Patrizi, S. T., Apollo, F., et al. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.03.010 · Cited by 36
Gossye, H., Van Broeckhoven, C., & Engelborghs, S. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00757 · Cited by 34
Lei, L., Wu, Z., & Winklhofer, K. F. (2020) · Matrix Biology · doi:10.1016/j.matbio.2020.11.003 · Cited by 33
Multiple Proteinopathies in Familial ALS Cases With Optineurin Mutations
Ayaki, T., Ito, H., Komure, O., Kamada, M., Nakamura, M., Wate, R., Kusaka, H., Yamaguchi, Y., Li, F., Kawakami, H., et al. (2017) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlx109 · Cited by 35
Pensato, V., Magri, S., Bella, E. D., Tannorella, P., Bersano, E., Sorarú, G., Gatti, M., Ticozzi, N., Taroni, F., Lauria, G., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9020412 · Cited by 35
Anoar, S., Woodling, N. S., & Niccoli, T. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.786076 · Cited by 37
Sreedharan, J., Blakeney, I., & Brown, R. H. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-813866-3.00020-5 · Cited by 32
Normal-tension glaucoma is associated with cognitive impairment
Mullany, S., Xiao, L., Qassim, A., Marshall, H., Gharahkhani, P., MacGregor, S., Hassall, M., Siggs, O. M., Souzeau, E., & Craig, J. E. (2021) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2020-317461 · Cited by 34
New ALS‐Related Genes Expand the Spectrum Paradigm of Amyotrophic Lateral Sclerosis
Sabatelli, M., Marangi, G., Conte, A., Tasca, G. A., Zollino, M., & Lattante, S. (2016) · Brain Pathology · doi:10.1111/bpa.12354 · Cited by 32
Autophagy and lysosomal pathways in nervous system disorders
Bingol, B. (2018) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2018.04.009 · Cited by 32
RNA Editing and Retrotransposons in Neurology
Krestel, H. E., & Meier, J. C. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00163 · Cited by 32
Caroppo, P., Camuzat, A., de Septenville, A. L., Couratier, P., Lacomblez, L., Auriacombe, S., Flabeau, O., Jornéa, L., Blanc, F., Sellal, F., et al. (2015) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2015.10.002 · Cited by 33
Ruffo, P., Traynor, B. J., & Conforti, F. L. (2025) · Journal of Neurology · doi:10.1007/s00415-025-12975-8 · Cited by 34
Rare nonsynonymous variants in SORT1 are associated with increased risk for frontotemporal dementia
Philtjens, S., Van Mossevelde, S., van der Zee, J., Wauters, E., Dillen, L., Vandenbulcke, M., Vandenberghe, R., Ivanoiu, A., Sieben, A., Willems, C., et al. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.02.011 · Cited by 25
Ciani, M., Benussi, L., Bonvicini, C., & Ghidoni, R. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00506 · Cited by 32
Recent advances in understanding frontotemporal degeneration
Borroni, B., & Benussi, A. (2019) · F1000Research · doi:10.12688/f1000research.20330.1 · Cited by 30
Emerging Trends in the Field of Inflammation and Proteinopathy in ALS/FTD Spectrum Disorder
Marchi, F. D., Franjkic, T., Schito, P., Russo, T., Nimac, J., Chami, A. A., Mele, A., Vidatic, L., Križ, J., Julien, J., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11061599 · Cited by 30
Familial normal tension glaucoma genetics
Fox, A. R., & Fingert, J. H. (2023) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2023.101191 · Cited by 32
SQSTM1/p62 variants in 486 patients with familial ALS from Germany and Sweden
Yilmaz, R., Müller, K., Brenner, D., Volk, A. E., Borck, G., Hermann, A., Meitinger, T., Strom, T. M., Danzer, K. M., Ludolph, A. C., et al. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.10.018 · Cited by 30
Foster, A., Downing, P., Figredo, E., Polain, N., Stott, A., Layfield, R., & Rea, S. L. (2020) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2020.103539 · Cited by 29
Hemizygous deletion of Tbk1 worsens neuromuscular junction pathology in TDP-43 transgenic mice
Sieverding, K., Ulmer, J., Bruno, C., Satoh, T., Tsao, W., Freischmidt, A., Akira, S., Wong, P. C., Ludolph, A. C., Danzer, K. M., et al. (2020) · Experimental Neurology · doi:10.1016/j.expneurol.2020.113496 · Cited by 30
Genome-wide structural variant analysis identifies risk loci for non-Alzheimer’s dementias
Kaivola, K., Chia, R., Ding, J., Rasheed, M., Fujita, M., Menon, V., Walton, R. L., Collins, R. L., Billingsley, K. J., Brand, H., et al. (2023) · Cell Genomics · doi:10.1016/j.xgen.2023.100316 · Cited by 28
Self-citationGenetic Diversity in Frontotemporal Dementia
Shpilyukova, Y. A., Fedotova, E. Y., & Illarioshkin, S. N. (2020) · Molecular Biology · doi:10.1134/s0026893320010136 · Cited by 28
Neuroinflammatory Pathways in the ALS-FTD Continuum: A Focus on Genetic Variants
Marchi, F. D., Tondo, G., Corrado, L., Menegon, F., Aprile, D., Anselmi, M., D’Alfonso, S., Comi, C., & Mazzini, L. (2023) · Genes · doi:10.3390/genes14081658 · Cited by 31
Almeida, S., Gao, F., Coppola, G., & Gao, F. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.03.001 · Cited by 28
Optineurin Functions for Optimal Immunity
Slowicka, K., & Loo, G. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00769 · Cited by 32
A novel TBK1 mutation in a family with diverse frontotemporal dementia spectrum disordersPreprint
Lamb, R., Rohrer, J. D., Real, R., Lubbe, S. J., Waite, A. J., Blake, D. J., Walters, R. J., Lashley, T., Révész, T., Holton, J. L., et al. (2019) · Molecular Case Studies · doi:10.1101/mcs.a003913 · Cited by 31
Pottier, C. P., Rampersaud, E., Baker, M. C., Wu, G., Wuu, J., McCauley, J. L., Zuchner, S. L., Schüle, R., Bermudez, C., Hussain, S., et al. (2018) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2018.1452947 · Cited by 27
Self-citationReview: Molecular pathology of frontotemporal lobar degenerations
Borroni, B., Alberici, A., & Buratti, E. (2018) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12534 · Cited by 26
Molecular Recognition of M1-Linked Ubiquitin Chains by Native and Phosphorylated UBAN Domains
Herhaus, L., van den Bedem, H., Tang, S., Maslennikov, I., Wakatsuki, S., Đikić, I., & Rahighi, S. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.06.012 · Cited by 27
Pottier, C. P., Küçükali, F., Baker, M. C., Batzler, A. J., Jenkins, G. D., van Blitterswijk, M., Vicente, C. T., Coster, W. D., Wynants, S., de Walle, P. V., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-59216-0 · Cited by 28
Self-citationClinical variability and onset age modifiers in an extended Belgian GRN founder family
Wauters, E., Mossevelde, S. V., Sleegers, K., van der Zee, J., Engelborghs, S., Sieben, A., Vandenberghe, R. R., Philtjens, S., den Broeck, M. V., Peeters, K., et al. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.03.007 · Cited by 26
Mol, M. O., Miedema, S. S. M., Swieten, J. C. V., van Rooij, J., & Dopper, E. G. P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910298 · Cited by 23
Cascella, R., Fani, G., Bigi, A., Chiti, F., & Cecchi, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20153685 · Cited by 25
Genetic Testing for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
Roggenbuck, J., & Fong, J. C. (2020) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2020.05.002 · Cited by 24
Neuroprotective activity of ursodeoxycholic acid in CHMP2B models of frontotemporal dementia
West, R. J. H., Ugbode, C., Fort‐Aznar, L., & Sweeney, S. T. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105047 · Cited by 27
A TBK1 variant causes autophagolysosomal and motoneuron pathology without neuroinflammation in mice
Brenner, D., Sieverding, K., Srinidhi, J., Zellner, S., Secker, C., Yilmaz, R., Dyckow, J., Amr, S., Ponomarenko, A., Tunaboylu, E., et al. (2024) · The Journal of Experimental Medicine · doi:10.1084/jem.20221190 · Cited by 24
Bartoletti‐Stella, A., Baiardi, S., Maserati, M. S., Piras, S., Caffarra, P., Raggi, A., Pantieri, R., Baldassari, S., Caporali, L., Abu‐Rumeileh, S., et al. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.02.006 · Cited by 23
Prospects for gene replacement therapies in amyotrophic lateral sclerosis
Giovannelli, I., Higginbottom, A., Kirby, J., Azzouz, M., & Shaw, P. J. (2022) · Nature Reviews Neurology · doi:10.1038/s41582-022-00751-5 · Cited by 23
Mitochondria-associated membrane collapse impairs TBK1-mediated proteostatic stress response in ALS
Watanabe, S., Murata, Y., Oka, Y., Oiwa, K., Horiuchi, M., Iguchi, Y., Komine, O., Sobue, A., Katsuno, M., Ogi, T., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2315347120 · Cited by 25
Yamaguchi, Y., Ayaki, T., Li, F., Tsujimura, A., Kamada, M., Ito, H., Maki, T., Sawamoto, N., Urushitani, M., & Takahashi, R. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.03.036 · Cited by 22
Genetic architecture of motor neuron diseases
Chaudhary, R., Agarwal, V., Rehman, M., Kaushik, A. S., & Mishra, V. (2021) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2021.120099 · Cited by 24
Rodríguez, M. J., & Mahy, N. (2016) · Current Medicinal Chemistry · doi:10.2174/0929867324666161123091314 · Cited by 22
Parobková, E., & Matěj, R. (2021) · Diagnostics · doi:10.3390/diagnostics11030509 · Cited by 25
Genetic testing in dementia‐A medical genetics perspective
Huq, A. J., Sexton, A., Lacaze, P. A., Masters, C. L., Storey, E., Velakoulis, D., James, P. A., & Winship, I. (2021) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.5535 · Cited by 23
Tohnai, G., Nakamura, R., Sone, J., Nakatochi, M., Yokoi, D., Katsuno, M., Watanabe, H., Watanabe, H., Ito, M., Li, Y., et al. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.12.005 · Cited by 21
Sellami, L., Saracino, D., & Ber, I. L. (2020) · Revue Neurologique · doi:10.1016/j.neurol.2020.02.008 · Cited by 23
Mitochondrial damage triggers the concerted degradation of negative regulators of neuronal autophagy
Basak, B., & Holzbaur, E. L. F. (2025) · Nature Communications · doi:10.1038/s41467-025-62379-5 · Cited by 22
Gurfinkel, Y., Polain, N., Sonar, K., Nice, P. A., Mancera, R. L., & Rea, S. L. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105859 · Cited by 20
Swift, I. J., Bocchetta, M., Benotmane, H., Woollacott, I., Shafei, R., & Rohrer, J. D. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.08.014 · Cited by 20
Development of a specific live-cell assay for native autophagic flux
Safren, N., Tank, E. M. H., Malik, A. M., Chua, J. P., Santoro, N., & Barmada, S. J. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101003 · Cited by 18
Further development of biomarkers in amyotrophic lateral sclerosis
Blasco, H., Vourc’h, P., Pradat, P., Gordon, P. H., Andres, C. R., & Corcia, P. (2016) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2016.1199277 · Cited by 21
Jiao, B., Sun, Q., Yuan, Z., Wang, J., Zhou, L., Yan, X., Tang, B., & Shen, L. H. (2018) · Translational Neurodegeneration · doi:10.1186/s40035-018-0136-6 · Cited by 19
Common and rare TBK1 variants in early-onset Alzheimer disease in a European cohort
Verheijen, J., van der Zee, J., Gijselinck, I., den Bossche, T. V., Dillen, L., Heeman, B., Gómez‐Tortosa, E., Lladó, A., Sánchez‐Valle, R., Graff, C., et al. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.10.012 · Cited by 21
Neurodegenerative disorders of the human frontal lobes
Butler, P. M., & Chiong, W. (2019) · Handbook of clinical neurology · doi:10.1016/b978-0-12-804281-6.00021-5 · Cited by 20
RNA Helicases in Microsatellite Repeat Expansion Disorders and Neurodegeneration
Castelli, L. M., Benson, B. C., Huang, W.-P., Lin, Y.-H., & Hautbergue, G. M. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.886563 · Cited by 18
microRNA‐based predictor for diagnosis of frontotemporal dementia
Magen, I., Yacovzada, N., Warren, J. D., Heller, C., Swift, I., Bobeva, Y., Malaspina, A., Rohrer, J. D., Fratta, P., & Hornstein, E. (2023) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12916 · Cited by 12
Shu, S., Li, X. L., Liu, Q. F., Liu, F., Cui, B., Liu, M. S., Cui, L., Li, X., & Zhang, X. (2016) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2016.1183681 · Cited by 18
Farhan, S. M. K., Gendron, T. F., Petrucelli, L., Hegele, R. A., & Strong, M. J. (2017) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32606 · Cited by 18
Weinreich, M., Shepheard, S. R., Verber, N. S., Wyles, M., Heath, P. R., Highley, J. R., Kirby, J., & Shaw, P. J. (2019) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12578 · Cited by 19
Immune Signaling Kinases in Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD)
García-García, R., Martín-Herrero, L., Blanca-Pariente, L., Pérez-Cabello, J. A., & Roodveldt, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413280 · Cited by 17
Lysosomal TBK1 responds to amino acid availability to relieve Rab7-dependent mTORC1 inhibition
Talaia, G., Bentley‐DeSousa, A., & Ferguson, S. M. (2024) · The EMBO Journal · doi:10.1038/s44318-024-00180-8 · Cited by 18
Xu, T., Weng, L., Zhang, C., Xiao, X., Yang, Q., Zhu, Y., Zhou, Y., Liao, X., Luo, S., Wang, J., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14215 · Cited by 18
Hao, J., Wells, M. F., Niu, G., Juan, I. G. S., Limone, F., Fukuda, A., Leyton-Jaimes, M. F., Joseph, B. J., Qian, M., Mordes, D. A., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.10.11.464011 · Cited by 20
The diverse role of optineurin in pathogenesis of disease
Guo, Q., Wang, J., & Weng, Q. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114157 · Cited by 19
Pharmacogenomics of Dementia: Personalizing the Treatment of Cognitive and Neuropsychiatric Symptoms
Vuić, B., Milos, T., Tudor, L., Perković, M. N., Konjevod, M., Erjavec, G. N., Farkaš, V., Uzun, S., Mimica, N., & Štrac, D. Š. (2023) · Genes · doi:10.3390/genes14112048 · Cited by 17
Mitochondrial dysfunction, cause or consequence in neurodegenerative diseases?
Acker, Z. P. V., Leroy, T., & Annaert, W. G. (2024) · BioEssays · doi:10.1002/bies.202400023 · Cited by 20
Combined Pathologies in FTLD-TDP Types A and C
Gefen, T. D., Ahmadian, S. S., Mao, Q., Kım, G., Seckin, M. F., Bonakdarpour, B., Ramos, E. M., Coppola, G., Rademakers, R., Rogalski, E. J., et al. (2018) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nly018 · Cited by 16
Self-citationThe complex relationship between genotype, pathology and phenotype in familial dementia
Kwok, J. B., Loy, C. T., Dobson‐Stone, C., & Halliday, G. M. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105082 · Cited by 17
Metadata
- Authors
- Pottier, C., Bieniek, K. F., Finch, N., van de Vorst, M., Baker, M., Perkersen, R., Brown, P., Ravenscroft, T., van Blitterswijk, M., Nicholson, A. M., DeTure, M., Knopman, D. S., Josephs, K. A., Parisi, J. E., Petersen, R. C., Boylan, K. B., Boeve, B. F., Graff-Radford, N. R., Veltman, J. A., Gilissen, C., Murray, M. E., Dickson, D. W., & Rademakers, R.
- Affiliations
- Mayo Clinic (US)
- Radboud University Nijmegen (NL)
- Corresponding author
- Rademakers, Rosa
- ORCID
- Venue
- Acta Neuropathologica
- Published
- 2015-05-06
- Volume
- 130
- Issue
- 1
- Pages
- 77-92
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- PMC
- PMC4470809
- OpenAlex
- W239648239
- Cited by
- 312
- References
- 63
- Citations by year
- 2026: 8 · 2025: 21 · 2024: 14 · 2023: 18 · 2022: 16 · 2021: 32 · 2020: 48 · 2019: 32 · 2018: 38 · 2017: 34 · 2016: 37 · 2015: 14
- FWCI
- 28.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Acta Neuropathologica (publishedVersion)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (publishedVersion, other-oa)
- PubMed Central (acceptedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Research Publications (Maastricht University) (submittedVersion, other-oa)
- Funders
- National Institutes of Health (R01 AG037491, R01 NS076471, R01 NS080882, R01 AG026251, P50 AG016574, U01 AG006786)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- frontotemporal dementia, optineurin, TBK1, loss-of-function mutations, compound heterozygosity, copy number variation, single nucleotide variants, oligogenic inheritance, amyotrophic lateral sclerosis
- MeSH terms
- Aged, Aged, 80 and over, Brain, Female, Humans, Immunohistochemistry, Male, Mutation, RNA, Messenger, Blotting, Western, Cohort Studies, Gene Expression, Motor Neuron Disease, Protein Serine-Threonine Kinases, Sequence Analysis, DNA, Cell Cycle Proteins, Membrane Transport Proteins, Transcription Factor TFIIIA, DNA Copy Number Variations, Frontotemporal Lobar Degeneration
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
